Evolent Health, Inc.
For the period ended Mar 31, 2026. Filed May 7, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 7, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 5. Other Information
Retention Award Agreements
On May 5, 2026, in order to enhance the retention of certain key officers of the Company, the Compensation Committee of the Board of Directors authorized and approved retention award agreements (each, a “Retention Award Agreement”) with Messrs. Blackley, McCarthy and Weinberg (each, an “Executive”), in the aggregate amounts of $880,000 for Mr. Blackley, $660,000 for Mr. McCarthy and $350,000 for Mr. Weinberg. Under each Retention Award Agreement, the Executives will receive a cash award, payable in two installments of 50% on December 31, 2026 and July 1, 2027 (each, a “Retention Date”), subject to the continued employment of each Executive by the Company through each Retention Date.
The foregoing summary is not complete and is qualified in its entirety by reference to the form of Retention Award Agreement, filed herewith as Exhibit 10.1 and incorporated herein by reference.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.